An examination of HIV/AIDS patients who have excellent adherence to HAART

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 15, Issue 2, 2003, Pages 251-261

  Malcolm, S E ^c   Ng, J J ^a   Rosen, R K ^c   Stone, Valerie E ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Massachusetts General Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SOCIAL SUPPORT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE;

EID: 0346447982     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/0954012031000068399     Document Type: Article

References (26)

1. ANDREWS, L., FRIEDLAND, G. & MANNHEIMER, S. (2000). A method for assessing patient readiness to begin and adhere to highly antiretroviral therapy (HAART). XIII International AIDS Conference, Durban, South Africa, July (abstract ThB 4987).
2. ARNSTEN, J.H., DEMAS, P.A., HOMAYOON, F. ET AL. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417-1422.
3. BANGSBERG, D.R. & MOSS, A (1999). When should we delay highly active antiretroviral therapy? Journal of General Internal Medicine, 14, 446-447.
4. BANGSBERG, D.R., HECHT, F.M. & CLAGUE, H. ET AL. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435-442.
5. BROERS, B. ET AL. (1994). A cohort study of drug user's compliance with zidovudine treatment. Archives of Internal Medicine, 154, 1121-1127.
6. CELENTANO, D., HOGG, R.S., VLAHOV, D. ET AL. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 544-546.
7. CHEEVER, L. (1999). What do we know about adherence levels in different populations? Adherence to HIV: building a bridge to success. Presented at a workshop of The Forum for Collaborative HIV Research, Washington, DC, 15-16 November.
8. DIMATEO, M.R., LEPPER, H.S. & CROGHAN, T.W. (2000). Depression is a risk factor for noncompliance with medical treatment. Archives of Internal Medicine, 160, 2101-2107.
9. ELDRED, L., WU, A. & CHAISSON, R. (1998). Adherence to antiretroviral therapy and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 117-125.
10. FRIEDLAND, G. & WAINBERG, M. (1998). Public health implications of antiretroviral therapy and hiv drug resistance. Journal of the American Medical Association, 279, 1977-1983.
11. FRIEDLAND, G.H. & WILLIAMS, A. (1999). Attaining higher goals in HIV Treatment: the central importance of adherence. AIDS, 13, S61-S72.
12. HAUBRICH, R.H., LITTLE, S.J., CURRIER, J.S. ET AL. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13, 1099-1107.
13. HOLZEMER, W.L., CORLESS, I.B., NOKES, K.M. ET AL. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care & STDS, 13, 185-197.
14. JANZ, N.K. & BECKER, M. (1984). The Health Belief Model: a decade later. Health Education Quarterly, 11 (1), 1-47.
15. KALICHMAN, S.C., RAMACHANDRAN, B. & CATZ, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14, 267-273.
16. LERNER, B.H., GULICK, R.M. & DUBLER, N.N. (1998). Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Annals of Internal Medicine, 129, 573-578.
17. th Conference on Retroviruses and Opportunistic Infections (abstract 72).
18. MOSTASHARI, F., RILEY, E., SELWYN, P.A. & ALTICE, F. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune and Human Retrovirology, 18, 341-348.
19. PATERSON, D.L., SWINDELLS, S., MOHR, J. ET AL. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133 (1), 21-30.
20. SAMET, J.H., LIBMAN, H., STEGER, K.A. ET AL. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type-1: a cross-sections study in a municipal hospital clinic. American Journal of Medicine, 92, 495-502.
21. SCOTT, V., RICE, M. & T.H.E. COURSE (1999). Adherence to HIV: building a bridge to success. Presented at a workshop of The Forum for Collaborative HIV Research, Washington, DC, 15 November.
22. th World AIDS Conference, Geneva. AIDS, 12, 588 (abstract 32337).
23. STONE, V.E., CLARKE, J., LOVELL, J. ET AL. (1998b). HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. Journal of General Internal Medicine, 13, 586-593.
24. STRATHDEE, S.A. ET AL. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547-549.
25. th Conference on Retroviruses and Opportunistic Infections, Chicago (abstract 96).
26. WILLIAMS, A.B. (1999). Adherence to highly active antiretroviral therapy. Nursing Clinics of North America, 34, 113-129.